Keyphrases
In Vitro Study
100%
Somatostatin Analogs
100%
Bronchial Carcinoid
100%
Growth Hormone-releasing Hormone
100%
Octreotide
100%
SOM230
100%
Somatostatin Receptor Subtypes
71%
Potential Therapeutics
14%
Expression Pattern
14%
Quantitative PCR
14%
Expression Profile
14%
Primary Cell Culture
14%
Older Women
14%
Positive Staining
14%
Histological Examination
14%
In Vivo Response
14%
High Affinity
14%
In Vitro Response
14%
Neuroendocrine Tumor
14%
Potent Inhibitor
14%
Pasireotide
14%
Insulin-like Growth factor-1
14%
SST-1
14%
Pulmonary Mass
14%
Soluble Suppression of Tumorigenicity 2 (sST2)
14%
Carcinoid
14%
Neuroscience
In Vivo
100%
In Vitro
100%
Somatostatin Derivative
100%
Carcinoid
100%
Growth-Hormone-Releasing Hormone
100%
Pasireotide
72%
Octreotide
63%
Receptor Subtype
45%
Somatostatin Receptor
45%
Acromegaly
18%
Staining Technique
9%
Cell Culture
9%
Real-Time Polymerase Chain Reaction
9%
Somatostatin Receptor 2
9%
Blood Plasma
9%
Messenger RNA
9%
Medicine and Dentistry
In Vitro
100%
Bronchus Carcinoid
100%
Growth Hormone Releasing Factor
100%
Somatostatin Derivative
100%
Pasireotide
72%
Octreotide
63%
Receptor Subtype
45%
Somatostatin Receptor
45%
Secretion (Process)
18%
Acromegaly
18%
Therapeutic Agent
9%
Cell Culture
9%
Real-Time Polymerase Chain Reaction
9%
Neuroendocrine Tumor
9%
In Vitro Production
9%
Somatostatin Receptor 2
9%
Carcinoid
9%
Messenger RNA
9%
Pharmacology, Toxicology and Pharmaceutical Science
Somatostatin Derivative
100%
Bronchus Carcinoid
100%
Growth Hormone Releasing Factor
100%
Pasireotide
72%
Octreotide
63%
Receptor Subtype
45%
Somatostatin Receptor
45%
Acromegaly
18%
Cell Culture
9%
Neuroendocrine Tumor
9%
Carcinoid
9%
Somatostatin Receptor 2
9%
Messenger RNA
9%